Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19).
Journal
Journal of cardiovascular pharmacology
ISSN: 1533-4023
Titre abrégé: J Cardiovasc Pharmacol
Pays: United States
ID NLM: 7902492
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
14
4
2020
medline:
20
5
2020
entrez:
14
4
2020
Statut:
ppublish
Résumé
A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly across the globe since December 2019. Coronavirus disease 2019 (COVID-19) has a significantly higher mortality rate than seasonal influenza and has disproportionately affected older adults, especially those with cardiovascular disease and related risk factors. Adverse cardiovascular sequelae, such as myocarditis, acute myocardial infarction, and heart failure, have been reported in patients with COVID-19. No established treatment is currently available; however, several therapies, including remdesivir, hydroxychloroquine and chloroquine, and interleukin (IL)-6 inhibitors, are being used off-label and evaluated in ongoing clinical trials. Considering these therapies are not familiar to cardiovascular clinicians managing these patients, this review describes the pharmacology of these therapies in the context of their use in patients with cardiovascular-related conditions.
Identifiants
pubmed: 32282502
doi: 10.1097/FJC.0000000000000836
pmc: PMC7219860
pii: 00005344-202005000-00001
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
359-367Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002649
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
BMJ. 2011 Apr 06;342:d1642
pubmed: 21471172
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Travel Med Infect Dis. 2020 Mar - Apr;34:101663
pubmed: 32289548
N Engl J Med. 2002 Nov 28;347(22):1795-7
pubmed: 12456857
J Card Fail. 2020 May;26(5):370
pubmed: 32439095
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Chest. 2007 Apr;131(4):1006-12
pubmed: 17426203
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337
pubmed: 32087098
Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391
pubmed: 32169400
Curr Pharm Des. 2012;18(11):1519-30
pubmed: 22364136
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Crit Care Med. 2011 Nov;39(11):2440-6
pubmed: 21725239
Lupus. 2018 Apr;27(4):591-599
pubmed: 28992800
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219
pubmed: 32391667
BMJ. 2012 Jul 11;345:e4260
pubmed: 22786934
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Eur Respir J. 2010 Sep;36(3):646-54
pubmed: 20150207
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
Cancer J. 2014 Mar-Apr;20(2):119-22
pubmed: 24667956
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Feb 22;395(10224):e35-e36
pubmed: 32035018
Aging Cell. 2020 Jul;19(7):
pubmed: 32558150
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
Sci Rep. 2014 Nov 13;4:7027
pubmed: 25391767
J Am Coll Cardiol. 2020 Mar 24;75(11):1341-1350
pubmed: 32192661
Eur Heart J. 2020 May 14;41(19):1801-1803
pubmed: 32196087
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Ann Pharmacother. 2014 Jun;48(6):734-40
pubmed: 24615627
J Antimicrob Chemother. 2005 Jan;55(1):10-21
pubmed: 15590715
Ther Adv Infect Dis. 2013 Oct;1(5):155-65
pubmed: 25165550
Curr HIV/AIDS Rep. 2014 Sep;11(3):212-22
pubmed: 24950731
Clin Pharmacokinet. 1998 Oct;35(4):275-91
pubmed: 9812178
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
pubmed: 32054787
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
JAMA. 2013 Oct 23;310(16):1692-700
pubmed: 24108510
J Biol Chem. 2020 Apr 10;295(15):4773-4779
pubmed: 32094225
J Am Coll Cardiol. 2018 Jul 31;72(5):518-530
pubmed: 30049313
Science. 2020 Mar 27;367(6485):1434
pubmed: 32198292
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
Minerva Cardioangiol. 2020 Apr;68(2):61-64
pubmed: 32150358
Clin Pharmacokinet. 2013 Oct;52(10):815-31
pubmed: 23703578
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Curr Atheroscler Rep. 2008 Feb;10(1):61-70
pubmed: 18366987
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Ther Clin Risk Manag. 2015 Mar 19;11:449-67
pubmed: 25848291
Clin Infect Dis. 2008 Aug 15;47(4):567-74
pubmed: 18636958
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
PLoS One. 2019 Aug 1;14(8):e0220178
pubmed: 31369575
Heart. 2016 Dec 15;102(24):1953-1956
pubmed: 27686519
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Travel Med Infect Dis. 2019 Jul - Aug;30:9-18
pubmed: 31252170